A new analysis by PwC UK shows growth in non-performing loans of about 10% per year for the last four years (and worse before that). However, that number relies on company accounts, and may understate the problem. Continue reading PwC: Problem EU loans grow to 1.2T euro
When SARS broke out in China and Hong Kong several years ago, AT&T knew about it almost right away, because the pattern of long distance calls between the US and that region changed dramatically. Fast forward, now there is Google Flu Trends. Go ahead, click through. I’ll still be here when you come back. Continue reading Big Data, Public Health, and the Next Financial Crisis
A trial balloon aimed at exempting most small filers from XBRL was almost floated today at a Congressional hearing. See the Data Transparency Coalition’s blog for the details. It would seem that several Congressmen found the testimony of Kenneth Moch, from Chimerix, to be influential. Let’s look closer at that testimony. Continue reading Chimerix: How Much Did You Spend On XBRL?
I used to run. Now hiking, biking, and ballroom dancing are my preferred forms of exercise. You have to stress your body to build and preserve muscle. Stress testing is good for the financial system, also. Two recent stories show that the US market is training for triathalons while the Eurozone is still shopping for track suit that makes them look slimmer. Continue reading Voluntary Stress Testing
Most of us take breathing for granted, but as a child I suffered allergy related asthma problems. My father, over 80, uses an inhaler. Avoiding the overuse of medication, such as an inhaler, is important to lowering medical costs and improving quality of life. And that is where data comes in. Continue reading Open Data Standards and the Breath of Little Children
OK, I will admit that that is just about the most boring headline possible. Sadly there really is no way to make this important issue gripping in five words or less. But it does matter! Continue reading UK Competition Commision Relaxes Audit Stance
A recent MSRB study points out the failure of continuous disclosure rules to actually achieve their goal – better informed investors. We deserve much better. Continue reading EMMA: Stale Disclosure Is Not Continuous Disclosure